Flow Diverters Market by Product Type (Self-Expanding Flow Diverters, Balloon-Expandable Flow Diverters), Material Type (Metallic Flow Diverters, Hybrid Flow Diverters), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), Application (Intracranial Aneurysm Treatment, Carotid Artery Treatment, Vertebral Artery Treatment, Other Cerebral Artery Conditions), Distribution Channel (Direct Sales, Distributors) ? Global Insights & Forecast (2023 ? 2030)

As per Intent Market Research, the Flow Diverters Market was valued at USD 0.9 billion in 2024-e and will surpass USD 2.3 billion by 2030; growing at a CAGR of 13.3% during 2025 - 2030.

The flow diverters market is experiencing significant growth driven by the increasing prevalence of neurovascular disorders, particularly intracranial aneurysms, and the rising demand for minimally invasive procedures. Flow diverters, which act as stent-like devices, are designed to redirect blood flow away from aneurysms, encouraging natural vessel healing. Their use has revolutionized the treatment of complex aneurysms that were previously considered inoperable or high-risk through traditional methods.

The market growth is further bolstered by advancements in device technology, such as enhanced material durability, improved flexibility, and reduced procedural risks. Increasing awareness among patients and healthcare professionals about minimally invasive solutions, coupled with better healthcare infrastructure and reimbursement policies in developed regions, is propelling market expansion.

Self-Expanding Flow Diverters Are Largest Owing to Their Versatility

Self-expanding flow diverters hold the largest share in the product type segment due to their adaptability to diverse vascular anatomies and ease of deployment. These devices automatically expand to conform to the shape and size of blood vessels, ensuring precision in placement and enhanced treatment efficacy.

Their widespread use in treating large and complex aneurysms is driven by their proven safety and success rates. Continuous technological advancements in self-expanding designs have further improved patient outcomes and expanded the range of cases that can be treated effectively, cementing this segment’s dominance in the market.

Metallic Flow Diverters Dominate Material Segment Owing to Durability

Metallic flow diverters dominate the material type segment, primarily due to their superior strength, flexibility, and biocompatibility. These devices are typically made from advanced alloys like nitinol and cobalt-chromium, which provide the necessary structural integrity for effective blood flow diversion while minimizing the risk of complications.

Their robustness and proven track record in complex neurovascular procedures make metallic flow diverters the preferred choice among healthcare professionals. Ongoing advancements in material science, including coatings that enhance biocompatibility, continue to solidify their leading position in the market.

Hospitals Are Largest End-User Owing to Advanced Facilities

Hospitals represent the largest end-user segment in the flow diverters market, attributed to the high volume of neurovascular procedures conducted in these settings. Equipped with advanced diagnostic and surgical technologies, hospitals are the primary choice for treating complex aneurysms.

The availability of multidisciplinary teams and comprehensive postoperative care further reinforces hospitals' dominance. As the prevalence of neurovascular disorders rises globally, hospitals are likely to maintain their leading position, supported by investments in state-of-the-art equipment and training.

Intracranial Aneurysm Treatment Leads Applications Due to High Prevalence

Intracranial aneurysm treatment is the largest application segment, driven by the increasing diagnosis of aneurysms and the effectiveness of flow diverters in managing these conditions. These devices offer a minimally invasive alternative to traditional surgical techniques, reducing recovery times and procedural risks.

As awareness of the benefits of flow diverters grows, coupled with advancements in imaging and diagnostic techniques, the adoption of these devices for intracranial aneurysm treatment is expected to increase further, solidifying this segment’s leadership.

Direct Sales Channel Dominates Due to Manufacturer Engagement

Direct sales dominate the distribution channel segment, as manufacturers prioritize direct interactions with healthcare providers to ensure effective deployment and training. This approach allows for tailored solutions, better after-sales support, and streamlined supply chains, enhancing customer satisfaction.

By maintaining close relationships with hospitals, specialty clinics, and surgeons, manufacturers can gather valuable feedback for product improvements, further driving the growth of this distribution channel.

North America Leads Regional Market Owing to Advanced Infrastructure

North America is the largest regional market for flow diverters, supported by a robust healthcare infrastructure, high prevalence of neurovascular disorders, and widespread adoption of minimally invasive techniques. The United States plays a pivotal role, driven by substantial investments in research and development, favorable reimbursement policies, and a strong focus on patient outcomes.

The growing geriatric population and increasing awareness of advanced treatment options have further accelerated the adoption of flow diverters in this region. Technological advancements and ongoing clinical trials are expected to sustain North America’s leadership in the global market.

Competitive Landscape

The flow diverters market is highly competitive, with key players like Medtronic, Stryker, Terumo, and MicroVention leading innovation efforts. These companies focus on product development, clinical trials, and strategic collaborations to enhance their market presence.

Emerging players are entering the market with innovative designs and materials, intensifying competition. As the demand for minimally invasive neurovascular treatments grows, companies are expected to continue investing in research and partnerships to gain a competitive edge and meet the evolving needs of healthcare providers and patients.

Recent Developments:

• In December 2024, Medtronic PLC launched an advanced flow diverter technology, designed to improve patient outcomes by enhancing device flexibility and ease of deployment during intracranial aneurysm surgeries.
• In November 2024, Stryker Corporation received FDA approval for a new flow diverter system, which enhances safety features and reduces the risk of complications during stent deployment.
• In October 2024, Terumo Corporation expanded its flow diverter portfolio with the introduction of a hybrid device aimed at both intracranial aneurysms and carotid artery treatments.
• In September 2024, Johnson & Johnson introduced an innovative flow diverter system featuring enhanced imaging compatibility to assist in real-time procedural navigation.
• In August 2024, Penumbra, Inc. unveiled its new next-generation flow diverter for vertebral artery conditions, offering improved conformability and greater flexibility for difficult cases.

List of Leading Companies:

• Medtronic PLC
• Stryker Corporation
• Terumo Corporation
• Johnson & Johnson (DePuy Synthes)
• Abbott Laboratories
• Cerenovus (Johnson & Johnson)
• MicroVention, Inc. (Terumo)
• Penumbra, Inc.
• Endologix, Inc.
• Neurovasc (Medtronic)
• Vascular Solutions, Inc.
• Sequent Medical, Inc. (Terumo)
• Blockade Medical
• InNeuroCo, Inc.
• Embolx, Inc.

Report Scope: